

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | peptide cross-linking (GO:0018149) | 9.54910236 |
| 2 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 8.92734979 |
| 3 | very-low-density lipoprotein particle assembly (GO:0034379) | 8.70475362 |
| 4 | negative regulation of fibrinolysis (GO:0051918) | 8.36285663 |
| 5 | plasma lipoprotein particle assembly (GO:0034377) | 8.35207995 |
| 6 | regulation of keratinocyte differentiation (GO:0045616) | 7.86307682 |
| 7 | protein-lipid complex assembly (GO:0065005) | 7.44334812 |
| 8 | peptidyl-glutamic acid carboxylation (GO:0017187) | 7.35267923 |
| 9 | protein carboxylation (GO:0018214) | 7.35267923 |
| 10 | intestinal cholesterol absorption (GO:0030299) | 7.31462625 |
| 11 | low-density lipoprotein particle remodeling (GO:0034374) | 7.29428778 |
| 12 | regulation of fibrinolysis (GO:0051917) | 7.09169855 |
| 13 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 6.89195590 |
| 14 | regulation of apoptotic cell clearance (GO:2000425) | 6.87699874 |
| 15 | response to vitamin A (GO:0033189) | 6.81546940 |
| 16 | regulation of relaxation of muscle (GO:1901077) | 6.73449276 |
| 17 | regulation of protein activation cascade (GO:2000257) | 6.47327642 |
| 18 | regulation of complement activation (GO:0030449) | 6.43244131 |
| 19 | cholesterol efflux (GO:0033344) | 6.33965380 |
| 20 | plasma lipoprotein particle remodeling (GO:0034369) | 6.26150152 |
| 21 | protein-lipid complex remodeling (GO:0034368) | 6.26150152 |
| 22 | macromolecular complex remodeling (GO:0034367) | 6.26150152 |
| 23 | regulation of cholesterol esterification (GO:0010872) | 6.19714224 |
| 24 | plasma lipoprotein particle organization (GO:0071827) | 6.18860854 |
| 25 | purine nucleotide salvage (GO:0032261) | 6.12580057 |
| 26 | muscle organ morphogenesis (GO:0048644) | 5.95587278 |
| 27 | skeletal muscle contraction (GO:0003009) | 5.93141273 |
| 28 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 5.88150177 |
| 29 | regulation of cardioblast proliferation (GO:0003264) | 5.88150177 |
| 30 | protein-lipid complex subunit organization (GO:0071825) | 5.82405611 |
| 31 | long-chain fatty acid biosynthetic process (GO:0042759) | 5.80844725 |
| 32 | regulation of skeletal muscle contraction (GO:0014819) | 5.73327283 |
| 33 | keratinocyte differentiation (GO:0030216) | 5.67455444 |
| 34 | blood coagulation, intrinsic pathway (GO:0007597) | 5.65212270 |
| 35 | high-density lipoprotein particle remodeling (GO:0034375) | 5.55165942 |
| 36 | muscle filament sliding (GO:0030049) | 5.50786628 |
| 37 | actin-myosin filament sliding (GO:0033275) | 5.50786628 |
| 38 | regulation of skeletal muscle cell differentiation (GO:2001014) | 5.47968399 |
| 39 | regulation of plasminogen activation (GO:0010755) | 5.45632434 |
| 40 | plasma lipoprotein particle clearance (GO:0034381) | 5.39383384 |
| 41 | outer ear morphogenesis (GO:0042473) | 5.32275440 |
| 42 | regulation of cholesterol homeostasis (GO:2000188) | 5.28283250 |
| 43 | innate immune response in mucosa (GO:0002227) | 5.24754894 |
| 44 | coronary vasculature morphogenesis (GO:0060977) | 5.21451428 |
| 45 | intestinal absorption (GO:0050892) | 5.20269199 |
| 46 | reverse cholesterol transport (GO:0043691) | 5.16717124 |
| 47 | linoleic acid metabolic process (GO:0043651) | 5.09419518 |
| 48 | tooth mineralization (GO:0034505) | 5.09265350 |
| 49 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.08174305 |
| 50 | positive regulation of extracellular matrix organization (GO:1903055) | 4.77321140 |
| 51 | cellular response to epidermal growth factor stimulus (GO:0071364) | 4.75233313 |
| 52 | regulation of epidermal cell differentiation (GO:0045604) | 4.73814830 |
| 53 | lymph vessel development (GO:0001945) | 4.73030579 |
| 54 | negative regulation of protein activation cascade (GO:2000258) | 4.68636061 |
| 55 | cellular response to retinoic acid (GO:0071300) | 4.64787533 |
| 56 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 4.63873916 |
| 57 | regulation of bile acid biosynthetic process (GO:0070857) | 4.58135255 |
| 58 | low-density lipoprotein particle clearance (GO:0034383) | 4.54890149 |
| 59 | actin-mediated cell contraction (GO:0070252) | 4.43597955 |
| 60 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 4.43354008 |
| 61 | L-phenylalanine catabolic process (GO:0006559) | 4.41679209 |
| 62 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.41679209 |
| 63 | lung epithelium development (GO:0060428) | 4.39051297 |
| 64 | mucosal-associated lymphoid tissue development (GO:0048537) | 4.38349184 |
| 65 | Peyers patch development (GO:0048541) | 4.38349184 |
| 66 | negative regulation of cholesterol transport (GO:0032375) | 4.37083224 |
| 67 | negative regulation of sterol transport (GO:0032372) | 4.37083224 |
| 68 | proline metabolic process (GO:0006560) | 4.37049441 |
| 69 | regulation of cholesterol biosynthetic process (GO:0045540) | 4.30867274 |
| 70 | diacylglycerol metabolic process (GO:0046339) | 4.29155007 |
| 71 | negative regulation of thymocyte apoptotic process (GO:0070244) | 4.23996863 |
| 72 | lipoprotein metabolic process (GO:0042157) | 4.22953705 |
| 73 | L-phenylalanine metabolic process (GO:0006558) | 4.20017748 |
| 74 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.20017748 |
| 75 | regulation of penile erection (GO:0060405) | 4.09160804 |
| 76 | mucosal immune response (GO:0002385) | 4.08457445 |
| 77 | muscle cell fate commitment (GO:0042693) | 4.07096736 |
| 78 | histamine secretion (GO:0001821) | 4.05895723 |
| 79 | creatine metabolic process (GO:0006600) | 4.05040996 |
| 80 | complement activation, alternative pathway (GO:0006957) | 4.04723300 |
| 81 | cholesterol transport (GO:0030301) | 3.99093037 |
| 82 | sterol transport (GO:0015918) | 3.99093037 |
| 83 | cellular response to glucocorticoid stimulus (GO:0071385) | 3.96686019 |
| 84 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.96091349 |
| 85 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.96091349 |
| 86 | cholesterol homeostasis (GO:0042632) | 3.91659461 |
| 87 | positive regulation of steroid metabolic process (GO:0045940) | 3.90047622 |
| 88 | response to epidermal growth factor (GO:0070849) | 3.90034042 |
| 89 | positive regulation of blood coagulation (GO:0030194) | 3.89471300 |
| 90 | positive regulation of hemostasis (GO:1900048) | 3.89471300 |
| 91 | negative regulation of complement activation (GO:0045916) | 3.89021865 |
| 92 | sterol homeostasis (GO:0055092) | 3.88022818 |
| 93 | regulation of extracellular matrix organization (GO:1903053) | 3.87273575 |
| 94 | epidermal cell differentiation (GO:0009913) | 3.87150935 |
| 95 | organ or tissue specific immune response (GO:0002251) | 3.86197321 |
| 96 | embryonic viscerocranium morphogenesis (GO:0048703) | 3.83106292 |
| 97 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 3.82420347 |
| 98 | positive regulation of hormone metabolic process (GO:0032352) | 3.82260945 |
| 99 | cellular response to corticosteroid stimulus (GO:0071384) | 3.82129434 |
| 100 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.81943953 |
| 101 | phospholipid efflux (GO:0033700) | 3.81389568 |
| 102 | proline biosynthetic process (GO:0006561) | 3.79522927 |
| 103 | glutamate metabolic process (GO:0006536) | 3.76875450 |
| 104 | positive regulation of myotube differentiation (GO:0010831) | 3.74083770 |
| 105 | lipoxygenase pathway (GO:0019372) | 3.74061742 |
| 106 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.70560379 |
| 107 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.70560379 |
| 108 | negative regulation of sodium ion transport (GO:0010766) | 3.69568903 |
| 109 | plasma membrane repair (GO:0001778) | 3.68728165 |
| 110 | nephron epithelium morphogenesis (GO:0072088) | 3.65013479 |
| 111 | nephron tubule morphogenesis (GO:0072078) | 3.65013479 |
| 112 | regulation of humoral immune response (GO:0002920) | 3.61825386 |
| 113 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 3.61393968 |
| 114 | mature B cell differentiation involved in immune response (GO:0002313) | 3.60737723 |
| 115 | acute-phase response (GO:0006953) | 3.59722355 |
| 116 | positive regulation of hormone biosynthetic process (GO:0046886) | 3.59097405 |
| 117 | pinocytosis (GO:0006907) | 3.58579404 |
| 118 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.55945116 |
| 119 | cranial nerve morphogenesis (GO:0021602) | 3.54680525 |
| 120 | protein activation cascade (GO:0072376) | 3.51961077 |
| 121 | positive regulation of coagulation (GO:0050820) | 3.51886991 |
| 122 | fibrinolysis (GO:0042730) | 3.51451535 |
| 123 | establishment of skin barrier (GO:0061436) | 3.49506656 |
| 124 | positive regulation of protein depolymerization (GO:1901881) | 3.48397024 |
| 125 | striated muscle contraction (GO:0006941) | 3.48322228 |
| 126 | modified amino acid transport (GO:0072337) | 3.46296853 |
| 127 | negative regulation of blood coagulation (GO:0030195) | 3.46029443 |
| 128 | negative regulation of hemostasis (GO:1900047) | 3.46029443 |
| 129 | tricarboxylic acid cycle (GO:0006099) | 3.44228199 |
| 130 | actin filament-based movement (GO:0030048) | 3.41826077 |
| 131 | trivalent inorganic anion homeostasis (GO:0072506) | 3.40920950 |
| 132 | phosphate ion homeostasis (GO:0055062) | 3.40920950 |
| 133 | response to vitamin E (GO:0033197) | 3.36441318 |
| 134 | myotube differentiation (GO:0014902) | 3.32398829 |
| 135 | cell proliferation involved in metanephros development (GO:0072203) | 3.32010384 |
| 136 | regulation of germinal center formation (GO:0002634) | 3.31577690 |
| 137 | regulation of norepinephrine secretion (GO:0014061) | 3.30356103 |
| 138 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 3.30257282 |
| 139 | regulation of epidermis development (GO:0045682) | 3.29147736 |
| 140 | negative regulation of B cell apoptotic process (GO:0002903) | 3.26790693 |
| 141 | peptidyl-glutamic acid modification (GO:0018200) | 3.26000605 |
| 142 | lipid homeostasis (GO:0055088) | 3.24631247 |
| 143 | negative regulation of norepinephrine secretion (GO:0010700) | 3.22566039 |
| 144 | complement activation, classical pathway (GO:0006958) | 3.22025106 |
| 145 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 3.21048312 |
| 146 | response to prostaglandin (GO:0034694) | 3.20180177 |
| 147 | positive regulation of skeletal muscle tissue development (GO:0048643) | 3.18775604 |
| 148 | negative regulation of coagulation (GO:0050819) | 3.18508508 |
| 149 | cellular zinc ion homeostasis (GO:0006882) | 3.18147752 |
| 150 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.17253645 |
| 151 | positive regulation of T cell differentiation in thymus (GO:0033089) | 3.16884169 |
| 152 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 3.16102599 |
| 153 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.15674319 |
| 154 | vitamin transmembrane transport (GO:0035461) | 3.13004381 |
| 155 | cellular anion homeostasis (GO:0030002) | 3.12956534 |
| 156 | negative regulation of lipase activity (GO:0060192) | 3.11846421 |
| 157 | regulation of cholesterol metabolic process (GO:0090181) | 3.11399979 |
| 158 | regulation of water loss via skin (GO:0033561) | 3.11263500 |
| 159 | histamine transport (GO:0051608) | 3.10141821 |
| 160 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.10066799 |
| 161 | myofibril assembly (GO:0030239) | 3.09682065 |
| 162 | transepithelial transport (GO:0070633) | 3.08363105 |
| 163 | drinking behavior (GO:0042756) | 3.07563253 |
| 164 | regulation of extracellular matrix disassembly (GO:0010715) | 3.06346957 |
| 165 | negative regulation of humoral immune response (GO:0002921) | 3.06043777 |
| 166 | artery smooth muscle contraction (GO:0014824) | 3.06025026 |
| 167 | desmosome organization (GO:0002934) | 3.03708109 |
| 168 | response to muscle activity (GO:0014850) | 3.02627742 |
| 169 | keratinization (GO:0031424) | 20.6609715 |
| 170 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.99513440 |
| 171 | purine nucleobase biosynthetic process (GO:0009113) | 2.97011143 |
| 172 | sarcomere organization (GO:0045214) | 2.96240945 |
| 173 | regulation of cell proliferation involved in heart morphogenesis (GO:2000136) | 2.93965352 |
| 174 | adenosine metabolic process (GO:0046085) | 2.93960544 |
| 175 | nucleotide salvage (GO:0043173) | 2.93853622 |
| 176 | skeletal muscle fiber development (GO:0048741) | 2.88965655 |
| 177 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.83270202 |
| 178 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.83270202 |
| 179 | aspartate family amino acid catabolic process (GO:0009068) | 2.81719992 |
| 180 | skeletal muscle adaptation (GO:0043501) | 2.81543973 |
| 181 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.80769057 |
| 182 | pharyngeal system development (GO:0060037) | 2.79418798 |
| 183 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.79157652 |
| 184 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.78762768 |
| 185 | carnitine shuttle (GO:0006853) | 2.78466539 |
| 186 | otic vesicle formation (GO:0030916) | 2.67629455 |
| 187 | mature B cell differentiation (GO:0002335) | 2.66799246 |
| 188 | muscle contraction (GO:0006936) | 2.65469945 |
| 189 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.64271376 |
| 190 | negative regulation of ion transmembrane transporter activity (GO:0032413) | 2.63326151 |
| 191 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.62742182 |
| 192 | negative regulation of circadian rhythm (GO:0042754) | 2.60904726 |
| 193 | NADH metabolic process (GO:0006734) | 2.59727041 |
| 194 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.59688369 |
| 195 | 2-oxoglutarate metabolic process (GO:0006103) | 2.59026743 |
| 196 | cochlea morphogenesis (GO:0090103) | 2.58294433 |
| 197 | negative regulation of digestive system process (GO:0060457) | 2.57995836 |
| 198 | cell wall macromolecule catabolic process (GO:0016998) | 14.8793801 |
| 199 | cell wall macromolecule metabolic process (GO:0044036) | 14.8793801 |
| 200 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 13.6042537 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 8.73233151 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 8.66001264 |
| 3 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 4.82774853 |
| 4 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 4.08847763 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.74880394 |
| 6 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 3.56796871 |
| 7 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 3.33437742 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.08497018 |
| 9 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 3.05663685 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.99285095 |
| 11 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.97867863 |
| 12 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.94427426 |
| 13 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.90129759 |
| 14 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.66201956 |
| 15 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 2.37582966 |
| 16 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.34575687 |
| 17 | CTCF_27219007_Chip-Seq_Bcells_Human | 2.32588182 |
| 18 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.32335992 |
| 19 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.26080352 |
| 20 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.23195622 |
| 21 | CTCF_20526341_ChIP-Seq_ESCs_Human | 2.18078180 |
| 22 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.11991035 |
| 23 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.06737241 |
| 24 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.05759652 |
| 25 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 2.02027260 |
| 26 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.93076892 |
| 27 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.90943600 |
| 28 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.88986737 |
| 29 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.87353453 |
| 30 | VDR_22108803_ChIP-Seq_LS180_Human | 1.83728579 |
| 31 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.81794884 |
| 32 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.81603888 |
| 33 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.79837791 |
| 34 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.79650358 |
| 35 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.76776577 |
| 36 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.72405313 |
| 37 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.63803531 |
| 38 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.53542629 |
| 39 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.52776319 |
| 40 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.52314667 |
| 41 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.46468392 |
| 42 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.46046199 |
| 43 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.45796361 |
| 44 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.43258047 |
| 45 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.42560061 |
| 46 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.41959070 |
| 47 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.41868469 |
| 48 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.41820222 |
| 49 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.39923663 |
| 50 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.38977542 |
| 51 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.37684368 |
| 52 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.37638177 |
| 53 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.37055606 |
| 54 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.36343949 |
| 55 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.35037504 |
| 56 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.32504759 |
| 57 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.32322272 |
| 58 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.31252068 |
| 59 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.27576427 |
| 60 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.26401840 |
| 61 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.25352794 |
| 62 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.25202707 |
| 63 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.24752913 |
| 64 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.24323145 |
| 65 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.24201450 |
| 66 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.24180632 |
| 67 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.22982586 |
| 68 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.21654490 |
| 69 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.18839218 |
| 70 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.18442736 |
| 71 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.18440982 |
| 72 | CJUN_26792858_Chip-Seq_BT549_Human | 1.18099850 |
| 73 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.17912321 |
| 74 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.17098344 |
| 75 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.14007262 |
| 76 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.12049327 |
| 77 | RXR_22108803_ChIP-Seq_LS180_Human | 1.09594422 |
| 78 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.09425530 |
| 79 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09222152 |
| 80 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.08461925 |
| 81 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 1.08360893 |
| 82 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.08123002 |
| 83 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.08123002 |
| 84 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.07751113 |
| 85 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.07747892 |
| 86 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.07501643 |
| 87 | P68_20966046_ChIP-Seq_HELA_Human | 1.07093892 |
| 88 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.05735568 |
| 89 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.05482289 |
| 90 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.04883069 |
| 91 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.03343757 |
| 92 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.03050363 |
| 93 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.02557414 |
| 94 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.02215711 |
| 95 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.01815441 |
| 96 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.01333191 |
| 97 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.01047654 |
| 98 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.00926801 |
| 99 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.00722177 |
| 100 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99851190 |
| 101 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.99803328 |
| 102 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.99703867 |
| 103 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.99388933 |
| 104 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.99341760 |
| 105 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.99062828 |
| 106 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.97942876 |
| 107 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.96467718 |
| 108 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.95750647 |
| 109 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.95667287 |
| 110 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.95061998 |
| 111 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.94958240 |
| 112 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.94573941 |
| 113 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.94034087 |
| 114 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.93238677 |
| 115 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.91470950 |
| 116 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.90853847 |
| 117 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.90853847 |
| 118 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.90584634 |
| 119 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.90515018 |
| 120 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.90186914 |
| 121 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.89847011 |
| 122 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.89766712 |
| 123 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.89556484 |
| 124 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.88986544 |
| 125 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.88271000 |
| 126 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.88271000 |
| 127 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.88092819 |
| 128 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.87921430 |
| 129 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.87880748 |
| 130 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.87342946 |
| 131 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.87251735 |
| 132 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.87178664 |
| 133 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.87073889 |
| 134 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.86977413 |
| 135 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.86542405 |
| 136 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.86437712 |
| 137 | ERA_21632823_ChIP-Seq_H3396_Human | 0.85425418 |
| 138 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.85399826 |
| 139 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.85249612 |
| 140 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.84748371 |
| 141 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.84740827 |
| 142 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84687694 |
| 143 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.83219631 |
| 144 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.83188961 |
| 145 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.82847993 |
| 146 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.82450120 |
| 147 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.81577427 |
| 148 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.80551192 |
| 149 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.80145885 |
| 150 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.80050503 |
| 151 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.79847367 |
| 152 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.79299693 |
| 153 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.79029342 |
| 154 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.78471984 |
| 155 | SOX11_22085726_ChIP-Seq_ESNs_Mouse | 0.76634983 |
| 156 | ATF3_27146783_Chip-Seq_COLON_Human | 0.72894458 |
| 157 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.72289850 |
| 158 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.71714438 |
| 159 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.71318546 |
| 160 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.70167950 |
| 161 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.69536705 |
| 162 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.68769996 |
| 163 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.67570797 |
| 164 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.66879202 |
| 165 | KDM2B_26808549_Chip-Seq_K562_Human | 0.66007913 |
| 166 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.65000266 |
| 167 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.64413111 |
| 168 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.63845920 |
| 169 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.62781236 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003122_maternal_imprinting | 6.81296029 |
| 2 | MP0002234_abnormal_pharynx_morphology | 5.47837754 |
| 3 | MP0000751_myopathy | 5.11726802 |
| 4 | MP0003646_muscle_fatigue | 4.90856790 |
| 5 | MP0002796_impaired_skin_barrier | 4.88665282 |
| 6 | MP0005275_abnormal_skin_tensile | 4.21254379 |
| 7 | MP0005365_abnormal_bile_salt | 4.18280506 |
| 8 | MP0000749_muscle_degeneration | 4.00246846 |
| 9 | MP0000467_abnormal_esophagus_morphology | 3.74756219 |
| 10 | MP0001666_abnormal_nutrient_absorption | 3.54191568 |
| 11 | MP0003123_paternal_imprinting | 3.51902552 |
| 12 | MP0000566_synostosis | 3.44156855 |
| 13 | MP0002837_dystrophic_cardiac_calcinosis | 3.40282050 |
| 14 | MP0000762_abnormal_tongue_morphology | 3.30620917 |
| 15 | MP0004145_abnormal_muscle_electrophysio | 3.07143823 |
| 16 | MP0009697_abnormal_copulation | 2.87423739 |
| 17 | MP0000747_muscle_weakness | 2.79407418 |
| 18 | MP0005501_abnormal_skin_physiology | 2.66900642 |
| 19 | MP0002089_abnormal_postnatal_growth/wei | 2.60785358 |
| 20 | MP0003172_abnormal_lysosome_physiology | 2.60737546 |
| 21 | MP0000759_abnormal_skeletal_muscle | 2.56898075 |
| 22 | MP0002106_abnormal_muscle_physiology | 2.55851541 |
| 23 | MP0000678_abnormal_parathyroid_gland | 2.42851507 |
| 24 | MP0002095_abnormal_skin_pigmentation | 2.30032904 |
| 25 | MP0003121_genomic_imprinting | 2.26097303 |
| 26 | MP0009780_abnormal_chondrocyte_physiolo | 2.25784858 |
| 27 | MP0004130_abnormal_muscle_cell | 2.25234430 |
| 28 | MP0005408_hypopigmentation | 2.23800911 |
| 29 | MP0003252_abnormal_bile_duct | 2.20079185 |
| 30 | MP0006054_spinal_hemorrhage | 2.15635040 |
| 31 | MP0001243_abnormal_dermal_layer | 2.14563301 |
| 32 | MP0001915_intracranial_hemorrhage | 2.13678619 |
| 33 | MP0004185_abnormal_adipocyte_glucose | 2.12756063 |
| 34 | MP0004087_abnormal_muscle_fiber | 2.12182458 |
| 35 | MP0005369_muscle_phenotype | 2.07306685 |
| 36 | MP0005058_abnormal_lysosome_morphology | 2.06257503 |
| 37 | MP0000750_abnormal_muscle_regeneration | 2.05478295 |
| 38 | MP0004036_abnormal_muscle_relaxation | 2.02671043 |
| 39 | MP0002132_abnormal_respiratory_system | 1.98271043 |
| 40 | MP0000733_abnormal_muscle_development | 1.92801493 |
| 41 | MP0000371_diluted_coat_color | 1.88275300 |
| 42 | MP0002269_muscular_atrophy | 1.86764137 |
| 43 | MP0003868_abnormal_feces_composition | 1.85790193 |
| 44 | MP0010234_abnormal_vibrissa_follicle | 1.83016199 |
| 45 | MP0005620_abnormal_muscle_contractility | 1.76008800 |
| 46 | MP0005409_darkened_coat_color | 1.75137733 |
| 47 | MP0002332_abnormal_exercise_endurance | 1.70712166 |
| 48 | MP0003705_abnormal_hypodermis_morpholog | 1.63573359 |
| 49 | MP0000609_abnormal_liver_physiology | 1.61882303 |
| 50 | MP0005257_abnormal_intraocular_pressure | 1.58823259 |
| 51 | MP0010368_abnormal_lymphatic_system | 1.57482611 |
| 52 | MP0005666_abnormal_adipose_tissue | 1.55212502 |
| 53 | MP0002118_abnormal_lipid_homeostasis | 1.54108249 |
| 54 | MP0001879_abnormal_lymphatic_vessel | 1.52616739 |
| 55 | MP0004270_analgesia | 1.52491351 |
| 56 | MP0002249_abnormal_larynx_morphology | 1.51573426 |
| 57 | MP0005330_cardiomyopathy | 1.46968020 |
| 58 | MP0006036_abnormal_mitochondrial_physio | 1.45548590 |
| 59 | MP0003567_abnormal_fetal_cardiomyocyte | 1.43826716 |
| 60 | MP0009384_cardiac_valve_regurgitation | 1.42207185 |
| 61 | MP0003806_abnormal_nucleotide_metabolis | 1.39017792 |
| 62 | MP0005167_abnormal_blood-brain_barrier | 1.38985209 |
| 63 | MP0004264_abnormal_extraembryonic_tissu | 1.38720739 |
| 64 | MP0005266_abnormal_metabolism | 1.36022468 |
| 65 | MP0004272_abnormal_basement_membrane | 1.32178897 |
| 66 | MP0002933_joint_inflammation | 1.31285399 |
| 67 | MP0000470_abnormal_stomach_morphology | 1.28633047 |
| 68 | MP0000639_abnormal_adrenal_gland | 1.27708928 |
| 69 | MP0009840_abnormal_foam_cell | 1.26884820 |
| 70 | MP0002127_abnormal_cardiovascular_syste | 1.26179614 |
| 71 | MP0002972_abnormal_cardiac_muscle | 1.25834397 |
| 72 | MP0005332_abnormal_amino_acid | 1.22267388 |
| 73 | MP0002254_reproductive_system_inflammat | 1.21680999 |
| 74 | MP0003315_abnormal_perineum_morphology | 1.19843094 |
| 75 | MP0004084_abnormal_cardiac_muscle | 1.16973185 |
| 76 | MP0002938_white_spotting | 1.15703787 |
| 77 | MP0001270_distended_abdomen | 1.14322224 |
| 78 | MP0003183_abnormal_peptide_metabolism | 1.13137074 |
| 79 | MP0005076_abnormal_cell_differentiation | 1.11148396 |
| 80 | MP0003942_abnormal_urinary_system | 1.10919130 |
| 81 | MP0010771_integument_phenotype | 1.10829715 |
| 82 | MP0000579_abnormal_nail_morphology | 1.06734255 |
| 83 | MP0001216_abnormal_epidermal_layer | 1.05842668 |
| 84 | MP0004947_skin_inflammation | 1.03382202 |
| 85 | MP0005636_abnormal_mineral_homeostasis | 1.01355103 |
| 86 | MP0000598_abnormal_liver_morphology | 1.00966104 |
| 87 | MP0003950_abnormal_plasma_membrane | 1.00718836 |
| 88 | MP0003115_abnormal_respiratory_system | 1.00420255 |
| 89 | MP0004233_abnormal_muscle_weight | 0.99897528 |
| 90 | MP0005375_adipose_tissue_phenotype | 0.98635475 |
| 91 | MP0005464_abnormal_platelet_physiology | 0.98564985 |
| 92 | MP0001661_extended_life_span | 0.98520575 |
| 93 | MP0004215_abnormal_myocardial_fiber | 0.98433899 |
| 94 | MP0005084_abnormal_gallbladder_morpholo | 0.97157425 |
| 95 | MP0002075_abnormal_coat/hair_pigmentati | 0.95420458 |
| 96 | MP0003878_abnormal_ear_physiology | 0.94516151 |
| 97 | MP0005377_hearing/vestibular/ear_phenot | 0.94516151 |
| 98 | MP0004484_altered_response_of | 0.92488870 |
| 99 | MP0005670_abnormal_white_adipose | 0.88810545 |
| 100 | MP0000049_abnormal_middle_ear | 0.86045418 |
| 101 | MP0000003_abnormal_adipose_tissue | 0.84903587 |
| 102 | MP0002108_abnormal_muscle_morphology | 0.83881436 |
| 103 | MP0000647_abnormal_sebaceous_gland | 0.83552405 |
| 104 | MP0005451_abnormal_body_composition | 0.83242130 |
| 105 | MP0003943_abnormal_hepatobiliary_system | 0.82402401 |
| 106 | MP0002139_abnormal_hepatobiliary_system | 0.81042704 |
| 107 | MP0003221_abnormal_cardiomyocyte_apopto | 0.80174679 |
| 108 | MP0003656_abnormal_erythrocyte_physiolo | 0.78530998 |
| 109 | MP0002971_abnormal_brown_adipose | 0.78121917 |
| 110 | MP0000604_amyloidosis | 0.77879133 |
| 111 | MP0009642_abnormal_blood_homeostasis | 0.77653603 |
| 112 | MP0001299_abnormal_eye_distance/ | 0.76807807 |
| 113 | MP0003879_abnormal_hair_cell | 0.76468611 |
| 114 | MP0004043_abnormal_pH_regulation | 0.75871772 |
| 115 | MP0001544_abnormal_cardiovascular_syste | 0.75352550 |
| 116 | MP0005385_cardiovascular_system_phenoty | 0.75352550 |
| 117 | MP0008260_abnormal_autophagy | 0.74623397 |
| 118 | MP0001191_abnormal_skin_condition | 0.73253175 |
| 119 | MP0005410_abnormal_fertilization | 0.72306240 |
| 120 | MP0003136_yellow_coat_color | 0.71496120 |
| 121 | MP0002092_abnormal_eye_morphology | 0.71254004 |
| 122 | MP0001324_abnormal_eye_pigmentation | 0.71220094 |
| 123 | MP0005379_endocrine/exocrine_gland_phen | 0.70123451 |
| 124 | MP0009115_abnormal_fat_cell | 0.69554206 |
| 125 | MP0005220_abnormal_exocrine_pancreas | 0.69323720 |
| 126 | MP0010630_abnormal_cardiac_muscle | 0.68794128 |
| 127 | MP0003890_abnormal_embryonic-extraembry | 0.67144568 |
| 128 | MP0000920_abnormal_myelination | 0.67050530 |
| 129 | MP0003941_abnormal_skin_development | 0.66795081 |
| 130 | MP0008438_abnormal_cutaneous_collagen | 0.66624195 |
| 131 | MP0001756_abnormal_urination | 0.66596107 |
| 132 | MP0004019_abnormal_vitamin_homeostasis | 0.65223487 |
| 133 | MP0005164_abnormal_response_to | 0.64814606 |
| 134 | MP0008961_abnormal_basal_metabolism | 0.64179084 |
| 135 | MP0003453_abnormal_keratinocyte_physiol | 0.63975295 |
| 136 | MP0008569_lethality_at_weaning | 0.63531527 |
| 137 | MP0001286_abnormal_eye_development | 0.63222008 |
| 138 | MP0002160_abnormal_reproductive_system | 0.63119527 |
| 139 | MP0005085_abnormal_gallbladder_physiolo | 0.62813211 |
| 140 | MP0003632_abnormal_nervous_system | 0.62228761 |
| 141 | MP0000367_abnormal_coat/_hair | 0.62040933 |
| 142 | MP0000372_irregular_coat_pigmentation | 0.61996854 |
| 143 | MP0004858_abnormal_nervous_system | 0.61739827 |
| 144 | MP0003329_amyloid_beta_deposits | 0.61569285 |
| 145 | MP0000427_abnormal_hair_cycle | 0.61246625 |
| 146 | MP0002078_abnormal_glucose_homeostasis | 0.61120828 |
| 147 | MP0001293_anophthalmia | 0.60729197 |
| 148 | MP0001177_atelectasis | 0.59878620 |
| 149 | MP0009931_abnormal_skin_appearance | 0.59639730 |
| 150 | MP0002909_abnormal_adrenal_gland | 0.58991469 |
| 151 | MP0004859_abnormal_synaptic_plasticity | 0.58442956 |
| 152 | MP0000681_abnormal_thyroid_gland | 0.57983444 |
| 153 | MP0006138_congestive_heart_failure | 0.57780196 |
| 154 | MP0002233_abnormal_nose_morphology | 0.57774108 |
| 155 | MP0009643_abnormal_urine_homeostasis | 0.57163119 |
| 156 | MP0000767_abnormal_smooth_muscle | 0.57080946 |
| 157 | MP0003566_abnormal_cell_adhesion | 0.56419066 |
| 158 | MP0000858_altered_metastatic_potential | 0.56219539 |
| 159 | MP0005448_abnormal_energy_balance | 0.55173505 |
| 160 | MP0003953_abnormal_hormone_level | 0.54695088 |
| 161 | MP0002166_altered_tumor_susceptibility | 0.54489710 |
| 162 | MP0009250_abnormal_appendicular_skeleto | 0.54205019 |
| 163 | MP0001186_pigmentation_phenotype | 0.54131844 |
| 164 | MP0003137_abnormal_impulse_conducting | 0.53013199 |
| 165 | MP0006292_abnormal_olfactory_placode | 0.52589346 |
| 166 | MP0005360_urolithiasis | 0.52437282 |
| 167 | MP0000534_abnormal_ureter_morphology | 0.52058293 |
| 168 | MP0001764_abnormal_homeostasis | 0.51802316 |
| 169 | MP0004883_abnormal_blood_vessel | 0.51569636 |
| 170 | MP0005319_abnormal_enzyme/_coenzyme | 0.49635346 |
| 171 | MP0002086_abnormal_extraembryonic_tissu | 0.49350239 |
| 172 | MP0002876_abnormal_thyroid_physiology | 0.49135507 |
| 173 | MP0008775_abnormal_heart_ventricle | 0.48316249 |
| 174 | MP0003195_calcinosis | 0.47437049 |
| 175 | MP0003755_abnormal_palate_morphology | 0.46642616 |
| 176 | MP0000343_altered_response_to | 0.46319573 |
| 177 | MP0002060_abnormal_skin_morphology | 0.45343405 |
| 178 | MP0003075_altered_response_to | 0.45025015 |
| 179 | MP0008875_abnormal_xenobiotic_pharmacok | 0.44523151 |
| 180 | MP0000613_abnormal_salivary_gland | 0.43323684 |
| 181 | MP0000013_abnormal_adipose_tissue | 0.43138146 |
| 182 | MP0010329_abnormal_lipoprotein_level | 0.41313048 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged partial thromboplastin time (HP:0003645) | 7.21601782 |
| 2 | Distal arthrogryposis (HP:0005684) | 6.55259986 |
| 3 | Exercise-induced myalgia (HP:0003738) | 6.46896857 |
| 4 | Muscle fiber inclusion bodies (HP:0100299) | 6.37746423 |
| 5 | Joint hemorrhage (HP:0005261) | 6.35755148 |
| 6 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 6.35719957 |
| 7 | Nemaline bodies (HP:0003798) | 5.70260846 |
| 8 | Round ear (HP:0100830) | 5.44716723 |
| 9 | Hypobetalipoproteinemia (HP:0003563) | 5.33144482 |
| 10 | Complement deficiency (HP:0004431) | 5.18444588 |
| 11 | Ulnar deviation of the wrist (HP:0003049) | 5.16060045 |
| 12 | Abnormality of the common coagulation pathway (HP:0010990) | 5.01287622 |
| 13 | Exercise-induced muscle cramps (HP:0003710) | 5.00475064 |
| 14 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.96055698 |
| 15 | Type 1 muscle fiber predominance (HP:0003803) | 4.88395356 |
| 16 | Small epiphyses (HP:0010585) | 4.83591334 |
| 17 | Calf muscle hypertrophy (HP:0008981) | 4.81335697 |
| 18 | Increased connective tissue (HP:0009025) | 4.80976658 |
| 19 | Difficulty running (HP:0009046) | 4.78392151 |
| 20 | Absent phalangeal crease (HP:0006109) | 4.66912134 |
| 21 | Myopathic facies (HP:0002058) | 4.54959484 |
| 22 | Calcaneovalgus deformity (HP:0001848) | 4.54072488 |
| 23 | Myoglobinuria (HP:0002913) | 4.46407575 |
| 24 | Hypercholesterolemia (HP:0003124) | 4.38522359 |
| 25 | Glomerulonephritis (HP:0000099) | 4.33662345 |
| 26 | Xanthomatosis (HP:0000991) | 4.23631549 |
| 27 | Menorrhagia (HP:0000132) | 4.19466305 |
| 28 | Autoimmune thrombocytopenia (HP:0001973) | 4.18951807 |
| 29 | Muscle fiber splitting (HP:0003555) | 4.14965909 |
| 30 | Hemorrhage of the eye (HP:0011885) | 4.14211303 |
| 31 | Increased IgE level (HP:0003212) | 4.08227158 |
| 32 | Unilateral renal agenesis (HP:0000122) | 4.07342018 |
| 33 | Hyporeflexia of lower limbs (HP:0002600) | 4.05695574 |
| 34 | Abnormality of carpal bone ossification (HP:0006257) | 4.01762720 |
| 35 | Deformed tarsal bones (HP:0008119) | 4.01327111 |
| 36 | Broad alveolar ridges (HP:0000187) | 3.92059908 |
| 37 | Rimmed vacuoles (HP:0003805) | 3.87917832 |
| 38 | Abnormal finger flexion creases (HP:0006143) | 3.87114052 |
| 39 | Acanthocytosis (HP:0001927) | 3.80343687 |
| 40 | Abnormality of complement system (HP:0005339) | 3.75689547 |
| 41 | Increased variability in muscle fiber diameter (HP:0003557) | 3.70207282 |
| 42 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.59531730 |
| 43 | Congenital malformation of the right heart (HP:0011723) | 3.56573200 |
| 44 | Double outlet right ventricle (HP:0001719) | 3.56573200 |
| 45 | Abnormal tarsal ossification (HP:0008369) | 3.56444391 |
| 46 | Asymmetry of the thorax (HP:0001555) | 3.56177672 |
| 47 | Mesangial abnormality (HP:0001966) | 3.51324301 |
| 48 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.49796737 |
| 49 | Systemic lupus erythematosus (HP:0002725) | 3.49518142 |
| 50 | Autoimmune hemolytic anemia (HP:0001890) | 3.47437221 |
| 51 | Epiphyseal dysplasia (HP:0002656) | 3.44842613 |
| 52 | Flat acetabular roof (HP:0003180) | 3.43394975 |
| 53 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.40125399 |
| 54 | Hypolipoproteinemia (HP:0010981) | 3.38408314 |
| 55 | Broad palm (HP:0001169) | 3.35012252 |
| 56 | Spontaneous abortion (HP:0005268) | 3.31610516 |
| 57 | Abnormality of the calf musculature (HP:0001430) | 3.27353482 |
| 58 | Pancreatic islet-cell hyperplasia (HP:0004510) | 3.19564304 |
| 59 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 3.16412477 |
| 60 | Distal lower limb muscle weakness (HP:0009053) | 3.15580105 |
| 61 | EMG: myopathic abnormalities (HP:0003458) | 3.15554812 |
| 62 | Right ventricular cardiomyopathy (HP:0011663) | 3.14401984 |
| 63 | Vaginal fistula (HP:0004320) | 3.12069244 |
| 64 | Purpura (HP:0000979) | 3.10650500 |
| 65 | Abnormality of the aortic arch (HP:0012303) | 3.10373762 |
| 66 | Epidermoid cyst (HP:0200040) | 3.09524978 |
| 67 | Abnormality of the parathyroid morphology (HP:0011766) | 3.09310148 |
| 68 | Muscle stiffness (HP:0003552) | 3.07784420 |
| 69 | Cholelithiasis (HP:0001081) | 3.07059363 |
| 70 | Paralysis (HP:0003470) | 3.07022873 |
| 71 | Myotonia (HP:0002486) | 3.03063961 |
| 72 | Abnormal hand bone ossification (HP:0010660) | 3.02470934 |
| 73 | Abnormal ossification of hand bones (HP:0005921) | 3.02012321 |
| 74 | Congenital ichthyosiform erythroderma (HP:0007431) | 3.01370601 |
| 75 | Areflexia of lower limbs (HP:0002522) | 2.99957521 |
| 76 | Irregular epiphyses (HP:0010582) | 2.98221902 |
| 77 | Hyperthyroidism (HP:0000836) | 2.96074358 |
| 78 | Vascular calcification (HP:0004934) | 2.95614965 |
| 79 | Rhabdomyolysis (HP:0003201) | 2.92639447 |
| 80 | Distal lower limb amyotrophy (HP:0008944) | 2.90603343 |
| 81 | Hepatoblastoma (HP:0002884) | 2.86079471 |
| 82 | Abnormal gallbladder morphology (HP:0012437) | 2.80178683 |
| 83 | Difficulty climbing stairs (HP:0003551) | 2.76430874 |
| 84 | Cupped ribs (HP:0000887) | 2.75282834 |
| 85 | Abnormality of the calcaneus (HP:0008364) | 2.74653306 |
| 86 | Abnormality of B cell number (HP:0010975) | 2.74462777 |
| 87 | B lymphocytopenia (HP:0010976) | 2.74462777 |
| 88 | Abnormality of the nasal septum (HP:0000419) | 2.74401667 |
| 89 | Abnormality of the lumbar spine (HP:0100712) | 2.72204091 |
| 90 | Abnormality of the wing of the ilium (HP:0011867) | 2.70035908 |
| 91 | Flared iliac wings (HP:0002869) | 2.69882595 |
| 92 | Neck muscle weakness (HP:0000467) | 2.67592535 |
| 93 | Hypophosphatemic rickets (HP:0004912) | 2.60134647 |
| 94 | Gingival bleeding (HP:0000225) | 2.59150219 |
| 95 | Cardiovascular calcification (HP:0011915) | 2.56391339 |
| 96 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 2.56347769 |
| 97 | Absent epiphyses (HP:0010577) | 2.56347769 |
| 98 | Facial diplegia (HP:0001349) | 2.51785784 |
| 99 | Alacrima (HP:0000522) | 2.48795151 |
| 100 | Limited elbow extension (HP:0001377) | 2.45923328 |
| 101 | Diastasis recti (HP:0001540) | 2.45025678 |
| 102 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.43558456 |
| 103 | Frequent falls (HP:0002359) | 2.40603566 |
| 104 | Hypoplastic ischia (HP:0003175) | 2.38801021 |
| 105 | Protrusio acetabuli (HP:0003179) | 2.38728805 |
| 106 | Enlarged kidneys (HP:0000105) | 2.36361743 |
| 107 | Lower limb amyotrophy (HP:0007210) | 2.32949670 |
| 108 | Increased serum pyruvate (HP:0003542) | 2.32940778 |
| 109 | Mitral stenosis (HP:0001718) | 2.29008042 |
| 110 | Tetany (HP:0001281) | 2.27935459 |
| 111 | Abnormal foot bone ossification (HP:0010675) | 2.26608420 |
| 112 | Hypoplastic left heart (HP:0004383) | 2.25694377 |
| 113 | Short palpebral fissure (HP:0012745) | 2.25156740 |
| 114 | Potter facies (HP:0002009) | 2.22571919 |
| 115 | Facial shape deformation (HP:0011334) | 2.22571919 |
| 116 | Myocardial infarction (HP:0001658) | 2.21274014 |
| 117 | Skin nodule (HP:0200036) | 2.21125237 |
| 118 | Hepatocellular carcinoma (HP:0001402) | 2.20019819 |
| 119 | Wide nose (HP:0000445) | 2.19791219 |
| 120 | Abnormality of glycolysis (HP:0004366) | 2.18687380 |
| 121 | Abnormality of the acetabulum (HP:0003170) | 2.18501135 |
| 122 | Thrombophlebitis (HP:0004418) | 2.18305049 |
| 123 | Pigmentary retinal degeneration (HP:0001146) | 2.18173246 |
| 124 | Hypoalphalipoproteinemia (HP:0003233) | 2.14059463 |
| 125 | Conjugated hyperbilirubinemia (HP:0002908) | 2.10953808 |
| 126 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.10799803 |
| 127 | Shoulder girdle muscle weakness (HP:0003547) | 2.10382766 |
| 128 | Abnormality of pain sensation (HP:0010832) | 2.09887802 |
| 129 | Impaired pain sensation (HP:0007328) | 2.09887802 |
| 130 | Abnormality of the ischium (HP:0003174) | 2.09759565 |
| 131 | Thyroiditis (HP:0100646) | 2.06690132 |
| 132 | Arthropathy (HP:0003040) | 2.06647755 |
| 133 | Pelvic girdle muscle weakness (HP:0003749) | 2.06494340 |
| 134 | Hypoglycemic coma (HP:0001325) | 2.03691694 |
| 135 | Amblyopia (HP:0000646) | 2.03338871 |
| 136 | Scapular winging (HP:0003691) | 2.02184733 |
| 137 | Abnormality of the alveolar ridges (HP:0006477) | 2.01840471 |
| 138 | Oral leukoplakia (HP:0002745) | 11.6075431 |
| 139 | Deep venous thrombosis (HP:0002625) | 10.9679715 |
| 140 | Delusions (HP:0000746) | 1.99789240 |
| 141 | Supernumerary spleens (HP:0009799) | 1.99441082 |
| 142 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.98282053 |
| 143 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.98282053 |
| 144 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.98063299 |
| 145 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.98063299 |
| 146 | Metaphyseal irregularity (HP:0003025) | 1.98012972 |
| 147 | Abnormality of the intrinsic pathway (HP:0010989) | 1.97730120 |
| 148 | Seborrheic dermatitis (HP:0001051) | 1.97664240 |
| 149 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.97375726 |
| 150 | Fat malabsorption (HP:0002630) | 1.97183437 |
| 151 | Severe combined immunodeficiency (HP:0004430) | 1.96861528 |
| 152 | Nephritis (HP:0000123) | 1.96575246 |
| 153 | Neonatal death (HP:0003811) | 1.95948878 |
| 154 | Renal duplication (HP:0000075) | 1.92932880 |
| 155 | Nasal speech (HP:0001611) | 1.92898957 |
| 156 | Abnormality of the lacrimal duct (HP:0011481) | 1.91747197 |
| 157 | Neonatal short-limb short stature (HP:0008921) | 1.91233987 |
| 158 | Foot dorsiflexor weakness (HP:0009027) | 1.91180721 |
| 159 | Muscular dystrophy (HP:0003560) | 1.90455014 |
| 160 | Peritonitis (HP:0002586) | 1.89887726 |
| 161 | Hypertensive crisis (HP:0100735) | 1.88357222 |
| 162 | Widely patent fontanelles and sutures (HP:0004492) | 1.88121860 |
| 163 | Poikilocytosis (HP:0004447) | 1.86648715 |
| 164 | Rectal fistula (HP:0100590) | 1.86327648 |
| 165 | Rectovaginal fistula (HP:0000143) | 1.86327648 |
| 166 | Decreased lacrimation (HP:0000633) | 1.86208279 |
| 167 | Hyperkalemia (HP:0002153) | 1.85886379 |
| 168 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.84823314 |
| 169 | Ulnar deviation of finger (HP:0009465) | 1.84758898 |
| 170 | Intrahepatic cholestasis (HP:0001406) | 1.83897546 |
| 171 | Abnormality of the pubic bones (HP:0003172) | 1.82883852 |
| 172 | Exotropia (HP:0000577) | 1.82837337 |
| 173 | Coxa vara (HP:0002812) | 1.80246772 |
| 174 | Achilles tendon contracture (HP:0001771) | 1.80166377 |
| 175 | Ectropion (HP:0000656) | 1.79550520 |
| 176 | Abnormality of the peritoneum (HP:0002585) | 1.78222674 |
| 177 | Abnormality of the gallbladder (HP:0005264) | 1.78062373 |
| 178 | Intestinal fistula (HP:0100819) | 1.76844270 |
| 179 | Bifid scrotum (HP:0000048) | 1.75670271 |
| 180 | Supernumerary ribs (HP:0005815) | 1.74861388 |
| 181 | Gout (HP:0001997) | 1.73772292 |
| 182 | Abnormality of the Achilles tendon (HP:0005109) | 1.72987754 |
| 183 | Rickets (HP:0002748) | 1.72823548 |
| 184 | Abnormality of the foot musculature (HP:0001436) | 1.72649449 |
| 185 | Abnormality of the vitreous humor (HP:0004327) | 1.70895504 |
| 186 | Corneal erosion (HP:0200020) | 1.69628009 |
| 187 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.67815000 |
| 188 | Wrist flexion contracture (HP:0001239) | 1.67492829 |
| 189 | Palmoplantar keratoderma (HP:0000982) | 1.67456011 |
| 190 | Metatarsus adductus (HP:0001840) | 1.64791244 |
| 191 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.63051192 |
| 192 | Hypoplastic heart (HP:0001961) | 1.62963486 |
| 193 | Woolly hair (HP:0002224) | 1.62209498 |
| 194 | Proximal amyotrophy (HP:0007126) | 1.62122476 |
| 195 | Malignant hyperthermia (HP:0002047) | 1.61042464 |
| 196 | Combined immunodeficiency (HP:0005387) | 1.60194184 |
| 197 | Abnormality of the tricuspid valve (HP:0001702) | 1.58540239 |
| 198 | Truncus arteriosus (HP:0001660) | 1.57793246 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FGFR4 | 7.25890884 |
| 2 | FGFR3 | 5.27166000 |
| 3 | PIK3CG | 5.22415740 |
| 4 | ICK | 4.02311987 |
| 5 | OBSCN | 3.87307250 |
| 6 | CDK12 | 3.42029776 |
| 7 | TYRO3 | 3.27435459 |
| 8 | PHKG2 | 3.14838269 |
| 9 | PHKG1 | 3.14838269 |
| 10 | NEK1 | 2.86823307 |
| 11 | PDK4 | 2.66926695 |
| 12 | PDK3 | 2.66926695 |
| 13 | TRIB3 | 2.65858338 |
| 14 | MAP2K3 | 2.45072277 |
| 15 | FGFR2 | 2.36204737 |
| 16 | PINK1 | 2.09578578 |
| 17 | TTN | 10.9815290 |
| 18 | SIK2 | 1.94216816 |
| 19 | AKT3 | 1.82669375 |
| 20 | PDK2 | 1.78583076 |
| 21 | BCKDK | 1.70547144 |
| 22 | DMPK | 1.49813158 |
| 23 | PKN2 | 1.41183666 |
| 24 | MAPKAPK3 | 1.35677871 |
| 25 | NME1 | 1.35160158 |
| 26 | MAP2K4 | 1.34785714 |
| 27 | TAOK1 | 1.34490671 |
| 28 | EIF2AK1 | 1.26241415 |
| 29 | MAP3K7 | 1.24176306 |
| 30 | EPHA2 | 1.18738333 |
| 31 | MAPK12 | 1.10156433 |
| 32 | ERBB2 | 1.04025384 |
| 33 | SGK223 | 1.02442961 |
| 34 | SGK494 | 1.02442961 |
| 35 | CDK7 | 0.99642492 |
| 36 | MAP3K3 | 0.96287124 |
| 37 | MAP2K6 | 0.95740668 |
| 38 | NEK2 | 0.92585496 |
| 39 | CDC42BPA | 0.91929841 |
| 40 | IRAK3 | 0.91788985 |
| 41 | KSR2 | 0.85778760 |
| 42 | RIPK1 | 0.82968854 |
| 43 | FER | 0.80198626 |
| 44 | MAP3K11 | 0.79743751 |
| 45 | MATK | 0.77567012 |
| 46 | SGK3 | 0.77262800 |
| 47 | RPS6KB1 | 0.75123065 |
| 48 | CSNK1E | 0.68634571 |
| 49 | CAMK2A | 0.67778683 |
| 50 | BRSK1 | 0.66832542 |
| 51 | MAP3K9 | 0.66394050 |
| 52 | MAPK11 | 0.65797426 |
| 53 | NEK9 | 0.64980146 |
| 54 | BCR | 0.64559889 |
| 55 | EPHB1 | 0.63982782 |
| 56 | SGK2 | 0.63981812 |
| 57 | WNK4 | 0.63939800 |
| 58 | NTRK2 | 0.63819227 |
| 59 | ERN1 | 0.63622563 |
| 60 | PRKD1 | 0.62185977 |
| 61 | BRD4 | 0.61974228 |
| 62 | PAK6 | 0.61282071 |
| 63 | PTK6 | 0.58845970 |
| 64 | ERBB3 | 0.58158066 |
| 65 | CAMK1D | 0.54140609 |
| 66 | RPS6KB2 | 0.54078982 |
| 67 | MARK2 | 0.53196242 |
| 68 | PIK3CA | 0.52773923 |
| 69 | MTOR | 0.51441185 |
| 70 | CDK8 | 0.51033124 |
| 71 | LATS2 | 0.48212099 |
| 72 | MAP3K6 | 0.47695954 |
| 73 | SMG1 | 0.46961759 |
| 74 | LRRK2 | 0.46346974 |
| 75 | MAP3K1 | 0.45252244 |
| 76 | FLT3 | 0.43410430 |
| 77 | TAOK2 | 0.42761860 |
| 78 | CAMK2G | 0.41855751 |
| 79 | MAP3K2 | 0.41732193 |
| 80 | TYK2 | 0.41723873 |
| 81 | PRKCH | 0.41637920 |
| 82 | WNK1 | 0.40672225 |
| 83 | SGK1 | 0.40391774 |
| 84 | PDK1 | 0.39766342 |
| 85 | PDGFRB | 0.38782693 |
| 86 | CSF1R | 0.38781701 |
| 87 | PTK2 | 0.37691994 |
| 88 | BRSK2 | 0.37534358 |
| 89 | LIMK1 | 0.37334252 |
| 90 | PDPK1 | 0.37319888 |
| 91 | PKN1 | 0.36392739 |
| 92 | MAP3K5 | 0.36221094 |
| 93 | PRKAA2 | 0.34634299 |
| 94 | EPHA4 | 0.34274133 |
| 95 | SRC | 0.33728777 |
| 96 | ITK | 0.32701471 |
| 97 | CSNK2A2 | 0.32658676 |
| 98 | NTRK3 | 0.31687478 |
| 99 | MAP2K1 | 0.30957321 |
| 100 | DYRK1B | 0.30399915 |
| 101 | PAK3 | 0.30079671 |
| 102 | CDK4 | 0.29858036 |
| 103 | MELK | 0.28218153 |
| 104 | CSNK1D | 0.28103139 |
| 105 | BMX | 0.27913684 |
| 106 | YES1 | 0.27125355 |
| 107 | AKT2 | 0.26664156 |
| 108 | CDK19 | 0.26440868 |
| 109 | MAPKAPK2 | 0.25301041 |
| 110 | NTRK1 | 0.25166165 |
| 111 | CDK6 | 0.24953135 |
| 112 | RPS6KA3 | 0.24761074 |
| 113 | MAPK3 | 0.24716660 |
| 114 | IGF1R | 0.24557654 |
| 115 | TRPM7 | 0.23853522 |
| 116 | MUSK | 0.23011564 |
| 117 | MARK1 | 0.22982624 |
| 118 | CAMK1G | 0.22908534 |
| 119 | PRKACA | 0.22530697 |
| 120 | CDK1 | 0.22435592 |
| 121 | DDR2 | 0.22121168 |
| 122 | TGFBR2 | 0.22083887 |
| 123 | TIE1 | 0.21961814 |
| 124 | CSNK2A1 | 0.21322426 |
| 125 | CDK9 | 0.21257853 |
| 126 | EEF2K | 0.20670582 |
| 127 | ILK | 0.20401197 |
| 128 | RET | 0.20264021 |
| 129 | PRKG1 | 0.20182898 |
| 130 | ROCK2 | 0.19896388 |
| 131 | PDGFRA | 0.19811089 |
| 132 | PRKCZ | 0.19449085 |
| 133 | CAMKK1 | 0.19409524 |
| 134 | PRKACG | 0.18841320 |
| 135 | MAPK4 | 0.18272374 |
| 136 | MAPKAPK5 | 0.18254225 |
| 137 | MAPK1 | 0.17771167 |
| 138 | MAPK14 | 0.17096055 |
| 139 | ALK | 0.17015622 |
| 140 | GSK3B | 0.16654585 |
| 141 | ROCK1 | 0.16534630 |
| 142 | PRKACB | 0.15990865 |
| 143 | PRKD3 | 0.15894499 |
| 144 | CDK5 | 0.15858245 |
| 145 | FGFR1 | 0.15527544 |
| 146 | MINK1 | 0.15500051 |
| 147 | MST1R | 0.14846556 |
| 148 | STK39 | 0.14639868 |
| 149 | JAK2 | 0.14148120 |
| 150 | DAPK2 | 0.13017810 |
| 151 | PTK2B | 0.12168655 |
| 152 | CAMK4 | 0.11445916 |
| 153 | SIK1 | 0.10893363 |
| 154 | PRKAA1 | 0.10777602 |
| 155 | FGR | 0.10496882 |
| 156 | EPHB2 | 0.09688882 |
| 157 | PAK2 | 0.09664275 |
| 158 | LATS1 | 0.09505682 |
| 159 | FYN | 0.08885957 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 6.17248304 |
| 2 | Salivary secretion_Homo sapiens_hsa04970 | 4.41387115 |
| 3 | Fat digestion and absorption_Homo sapiens_hsa04975 | 4.03369654 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.95509372 |
| 5 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 3.91503405 |
| 6 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.55308539 |
| 7 | Steroid biosynthesis_Homo sapiens_hsa00100 | 3.24936132 |
| 8 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.13172895 |
| 9 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 2.69289181 |
| 10 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.37028245 |
| 11 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 2.27716564 |
| 12 | Other glycan degradation_Homo sapiens_hsa00511 | 2.22550063 |
| 13 | Histidine metabolism_Homo sapiens_hsa00340 | 2.10980576 |
| 14 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.10513364 |
| 15 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 2.05974093 |
| 16 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.00593353 |
| 17 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.93620068 |
| 18 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.93547900 |
| 19 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.89238368 |
| 20 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.84988671 |
| 21 | Carbon metabolism_Homo sapiens_hsa01200 | 1.84096743 |
| 22 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.70308495 |
| 23 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.68292262 |
| 24 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.62027499 |
| 25 | Alzheimers disease_Homo sapiens_hsa05010 | 1.60819229 |
| 26 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.57717088 |
| 27 | ABC transporters_Homo sapiens_hsa02010 | 1.53514919 |
| 28 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.53439660 |
| 29 | Parkinsons disease_Homo sapiens_hsa05012 | 1.49513455 |
| 30 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.45125255 |
| 31 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.43962060 |
| 32 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.41200214 |
| 33 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.40058285 |
| 34 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.34716571 |
| 35 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.31220867 |
| 36 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.30525156 |
| 37 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.29626068 |
| 38 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.28864233 |
| 39 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.27493155 |
| 40 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.27485420 |
| 41 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.27175807 |
| 42 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.25529430 |
| 43 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.24992860 |
| 44 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.23869013 |
| 45 | Olfactory transduction_Homo sapiens_hsa04740 | 1.21887268 |
| 46 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.16898683 |
| 47 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.15611310 |
| 48 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.11602382 |
| 49 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.09848163 |
| 50 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.09740102 |
| 51 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.08908628 |
| 52 | Phototransduction_Homo sapiens_hsa04744 | 1.06871602 |
| 53 | Renin secretion_Homo sapiens_hsa04924 | 1.03944319 |
| 54 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.00785442 |
| 55 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.00576253 |
| 56 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.96341395 |
| 57 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.95036641 |
| 58 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.94333707 |
| 59 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.93891082 |
| 60 | Lysine degradation_Homo sapiens_hsa00310 | 0.93625315 |
| 61 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.92619988 |
| 62 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.92273594 |
| 63 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.88855715 |
| 64 | Long-term potentiation_Homo sapiens_hsa04720 | 0.86685308 |
| 65 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.82233271 |
| 66 | Circadian entrainment_Homo sapiens_hsa04713 | 0.81631147 |
| 67 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.78928297 |
| 68 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.78143279 |
| 69 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.77317134 |
| 70 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.76564012 |
| 71 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.75045327 |
| 72 | Insulin resistance_Homo sapiens_hsa04931 | 0.72838149 |
| 73 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.72534701 |
| 74 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.72191526 |
| 75 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.71988882 |
| 76 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.70454807 |
| 77 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.70130738 |
| 78 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.69787941 |
| 79 | Prion diseases_Homo sapiens_hsa05020 | 0.68188631 |
| 80 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.67466423 |
| 81 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.67322611 |
| 82 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.65334179 |
| 83 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.64656009 |
| 84 | Glioma_Homo sapiens_hsa05214 | 0.64191232 |
| 85 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.61323165 |
| 86 | Retinol metabolism_Homo sapiens_hsa00830 | 0.60979905 |
| 87 | Huntingtons disease_Homo sapiens_hsa05016 | 0.60711789 |
| 88 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.60110050 |
| 89 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.59546704 |
| 90 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.58799038 |
| 91 | Mineral absorption_Homo sapiens_hsa04978 | 0.58169877 |
| 92 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.57590292 |
| 93 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.57333014 |
| 94 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.56769916 |
| 95 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.55900997 |
| 96 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.55867629 |
| 97 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.53033907 |
| 98 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.52389425 |
| 99 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.51775715 |
| 100 | Melanogenesis_Homo sapiens_hsa04916 | 0.50923188 |
| 101 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.47630674 |
| 102 | Long-term depression_Homo sapiens_hsa04730 | 0.44406876 |
| 103 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.43269732 |
| 104 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.43064634 |
| 105 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.42789648 |
| 106 | Pertussis_Homo sapiens_hsa05133 | 0.42470911 |
| 107 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.40737056 |
| 108 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.38211102 |
| 109 | Galactose metabolism_Homo sapiens_hsa00052 | 0.37962315 |
| 110 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.37227946 |
| 111 | Bile secretion_Homo sapiens_hsa04976 | 0.36993841 |
| 112 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.36737825 |
| 113 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.36107083 |
| 114 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.35091744 |
| 115 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.34633669 |
| 116 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.34425986 |
| 117 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.32534765 |
| 118 | Adherens junction_Homo sapiens_hsa04520 | 0.32033235 |
| 119 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.31494265 |
| 120 | Tight junction_Homo sapiens_hsa04530 | 0.29288059 |
| 121 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.28018784 |
| 122 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25629144 |
| 123 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.25515339 |
| 124 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.25350220 |
| 125 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.24317263 |
| 126 | Circadian rhythm_Homo sapiens_hsa04710 | 0.23277843 |
| 127 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.22987440 |
| 128 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.22477712 |
| 129 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.21750362 |
| 130 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.21733014 |
| 131 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.21533383 |
| 132 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.20452010 |
| 133 | Peroxisome_Homo sapiens_hsa04146 | 0.20285066 |
| 134 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.20211999 |
| 135 | Insulin secretion_Homo sapiens_hsa04911 | 0.19494523 |
| 136 | Metabolic pathways_Homo sapiens_hsa01100 | 0.18789736 |
| 137 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.18415712 |
| 138 | Platelet activation_Homo sapiens_hsa04611 | 0.18412491 |
| 139 | GABAergic synapse_Homo sapiens_hsa04727 | 0.18347519 |
| 140 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.18094051 |
| 141 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.16894512 |
| 142 | Focal adhesion_Homo sapiens_hsa04510 | 0.16614558 |
| 143 | Lysosome_Homo sapiens_hsa04142 | 0.16612898 |
| 144 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.14977449 |
| 145 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.13852929 |
| 146 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.13780489 |
| 147 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.13624664 |
| 148 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.12373997 |
| 149 | Bladder cancer_Homo sapiens_hsa05219 | 0.09949443 |
| 150 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.09520988 |

